Christopher J. Coughlin, Director at Dipexium Pharmaceuticals, Inc. (DPRX), bought 2,083 shares at $12.00 ($25K) on 2014-03-18, disclosed to the SEC on 2014-03-20.
Open-market purchase of $25k DPRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CNC | BUY | 2022-05-03 | $976K | — | Filing → |
| AGN | BUY | 2018-09-07 | $3.5M | — | Filing → |
| ALXN | BUY | 2018-05-02 | $1.2M | — | Filing → |